Welcome to Medications.com

UPDATE: Mylan Swings To 4Q Loss On Generics Acquisitions - CNNMoney.com

The company is considering an at-risk launch of Johnson & Johnson's (JNJ) epilepsy drug Topamax in 2008 or 2009, meaning it will market the drug after the ...

http://money.cnn.com/news/newsfee... | Posted: Wed Feb 27 17:47:50 -0500 2008




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea